According to a market report by Lucintel, the future of the global anatomic pathology market looks promising with opportunities in the hospital, research laboratory, and diagnostic laboratory markets. The global anatomic pathology market is expected to reach an estimated $36.3 billion by 2028 with a CAGR of 6.1% from 2023 to 2028. The major drivers for this market are growing geriatric population, high frequency of cancer and other targeted diseases, and increasing adoption of clinical biomarkers to fix disease pathogenesis at the molecular level, which helps in clinical decision-making and improving patient outcomes.
In this market, instruments, consumables, and services are the different segments of anatomic pathology market by product. Lucintel forecasts that consumables will remain the largest segment over the forecast period due to increasing adoption of consumables in research findings owing to its cost effectiveness and easy availability of pathology consumables.
Within this market, hospitals segment will remain the largest segment because of the increasing hospitalization rate of cancer patients, growing adoption of in-house diagnostic procedures performed in hospitals as well as rising number of initiatives undertaken by the public and private agencies to promote advanced healthcare systems.
North America will remain the largest region over the forecast period due to, increasing awareness towards regular health screening, favourable reimbursement scenarios for diagnostic tests, government initiatives for cancer screening, and existence of key players in the region.
Danaher Corporation, PHC Holdings, Quest Diagnostics, F. Hoffmann-La Roche, Agilent Technologies, Cardinal Health, Sakura Finetek, NeoGenomics Laboratories, and BioGenex are the major suppliers in the global anatomic pathology market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected]